Stock 6990 SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Equities

6990

CNE1000062J1

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:32 29/05/2024 pm IST 		5-day change 1st Jan Change
158.5 HKD -4.52% Intraday chart for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. -10.25% +54.03%
24/05 Sichuan Kelun-biotech Biopharmaceutical to Present Its Cancer Drug Phase 3 Study Results at ASCO MT
24/05 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Announces Results for Core Product Sacituzumab Tirumotecan(Sac-Tmt) At 2024 Asco Annual Meeting CI

Business Summary

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.

Number of employees: 1,446

Sales per Business

HKD in Million2022Weight2023Weight Delta
Novel Drugs
100.0 %
935 100.0 % 1,702 100.0 % +82.08%

Sales per region

HKD in Million2022Weight2023Weight Delta
United States
99.2 %
849 90.8 % 1,689 99.2 % +98.92%
China
0.5 %
66 7.0 % 8 0.5 % -87.31%
Other Countries
0.3 %
20 2.2 % 5 0.3 % -74.20%

Managers

Managers TitleAgeSince
Jun You Ge CEO
 Chief Executive Officer 51 08/21/08
Ze Jian Zhou DFI
 Director of Finance/CFO 41 25/22/25
Xiang Yang Tan CTO
 Chief Tech/Sci/R&D Officer 61 05/21/05
Xiao Ping Jin CTO
 Chief Tech/Sci/R&D Officer 47 06/21/06
Yi Wei Zhang PRN
 Corporate Officer/Principal 68 09/18/09
Yi Feng PRN
 Corporate Officer/Principal 59 01/20/01
Wai Sum Fung SEC
 Corporate Secretary 41 30/23/30

Members of the board

Members of the board TitleAgeSince
Ge Xin Liu FOU
 Founder 73 22/16/22
Jin Ping Jin BRD
 Director/Board Member 52 15/23/15
Si Chuan Liu BRD
 Director/Board Member 40 22/16/22
Peng Wan BRD
 Director/Board Member 48 12/21/12
De Gui Lai CHM
 Chairman 52 12/21/12
Hao Feng BRD
 Director/Board Member 44 12/21/12
Wen Wei Tu BRD
 Director/Board Member 57 15/23/15
Hong Mei Song BRD
 Director/Board Member 41 18/19/18
Qiu Yan Yang BRD
 Director/Board Member 39 18/17/18
Yan Qing BRD
 Director/Board Member 40 01/21/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 92,571,094 91,645,383 ( 99.00 %) 0 55.98 %
Stock B 1 130,273,005 33,107,580 ( 25.41 %) 0

Shareholders

NameEquities%Valuation
SICHUAN KELUN PHARMACEUTICAL CO., LTD.
56.34 %
71,345,543 56.34 % 1 535 M $
MERCK & CO., INC.
10.62 %
13,443,693 10.62 % 289 M $
IDG Capital Partners Co., Ltd.
3.666 %
4,642,191 3.666 % 100 M $
Jun Li
3.317 %
4,200,000 3.317 % 90 M $
Wellington Management Group LLP
2.282 %
2,889,419 2.282 % 62 M $
Jing Yi Wang
2.251 %
2,850,000 2.251 % 61 M $
RTW Investments LP
1.528 %
1,934,400 1.528 % 42 M $
Wellington Management Hong Kong Ltd.
0.8860 %
1,121,841 0.8860 % 24 M $
China Universal Asset Management Co., Ltd.
0.8535 %
1,080,700 0.8535 % 23 M $
Trumed Health Partners LLC
0.7420 %
939,600 0.7420 % 20 M $
NameEquities%Valuation
SICHUAN KELUN PHARMACEUTICAL CO., LTD.
55.62 %
83,201,712 55.62 % 1 790 M $
Jing Yi Wang
1.905 %
2,850,000 1.905 % 61 M $
Jun You Ge
0.9827 %
1,470,000 0.9827 % 32 M $
Hong Mei Song
0.2106 %
315,000 0.2106 % 7 M $
De Gui Lai
0.1965 %
294,000 0.1965 % 6 M $
Hao Feng
0.1965 %
294,000 0.1965 % 6 M $
Yan Qing
0.1872 %
280,000 0.1872 % 6 M $
Qiu Yan Yang
0.1497 %
224,000 0.1497 % 5 M $

Company contact information

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

No. 666 Xinhua Avenue Chengdu Cross-Strait Science and

611100, Chengdu

+

address Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.(6990)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per region

Ratings for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
158.5 HKD
Average target price
194.7 HKD
Spread / Average Target
+22.83%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. Stock Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
+54.03% 473.58Cr
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+8.38% 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.13% 10TCr
BIONTECH SE Stock BioNTech SE
-11.69% 2.27TCr
ARGENX SE Stock argenx SE
+2.21% 2.18TCr
GENMAB A/S Stock Genmab A/S
-10.88% 1.82TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.90% 1.65TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-16.00% 1.6TCr
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.28% 1.41TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+20.54% 1.07TCr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6990 Stock
  4. Company Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.